Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
News Medical on MSN1d
CityUHK leads groundbreaking project to develop new platform for early cancer detectionCancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.
This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...
Professor Michael Yang (eighth from the left) and his research team.Cancer continues to be a leading cause of mortality ...
Researchers from Creatv Bio, Division of Creatv MicroTech, Inc. (Monmouth Junction, NJ) and The Mayo Clinic (Jacksonville, FL), in collaboration with BriaCell Therapeutics Corporation (Philadelphia, ...
The "Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Preoperative ...
Indian American professor recognized for his research program investigating cancer cell metabolism and his national ...
Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback